• Proceedings of the PSK Conference
• /
• 2003.10b
• /
• pp.169.1-169.1
• /
• 2003

Recently development of cell-based assay systems which are useful in molecular cell biology and drug discovery attracts significant attention. Here, we introduce a new technologies for monitoring enzyme activity and its inhibition inside living cells. Among various enzymes, proteases are important targets for studying various biological and disease-related processes such as viral infections, apoptosis and Alzheimer's disease. In this study, a sensitive cell-based protease detection system that enables direct fluorescence detection of a target protease and its inhibition inside living cells is introduced. (omitted)

• Journal of Integrative Natural Science
• /
• v.1 no.2
• /
• pp.79-83
• /
• 2008

As a new standard for performance measurement, NEMA NU2-2001 was presented recently. In this study, I investigated the spatial resolution, sensitivity, scatter fraction, and noise equivalent count ratio (NECR) in order to know the information of physical characteristics and system performance of GE discovery ST using this new standard. Bismuth germinate crystals ($6{\times}6$ array, $6.3mm{\times}6.3mm{\times}30mm$) were used in discovery ST (energy window:375-650 keV, coincidence window:11.7 nsec). To measure the sensitivity, five aluminum sleeves (Data Spectrum Corp., Chapel Hill, NC., USA, thickness:1.25 mm)-NEMA sensitivity phantom- filled with F-18 solution were used. Successive measurements in 2D and 3D acquisition mode were made with a line source at the center of transaxial field of view and 10 cm off from the center until the count was over 500,000. Spatial resolution was estimated using a point source (F-18, 0.1 mCi) at different locations in the FOV. Scatter fraction and NECR was tested using a NEMA scatter phantom. Dynamic data were acquired for 7 half-lives using F-18 solution. And true to background ratio was averaged at last three frames when the random rate was as small as ignorable for the calculation of scatter fraction. We anticipate this overall evaluated results could be used for the quality assurance and optimized image acquisition for clinical research.

• Journal of Integrative Natural Science
• /
• v.5 no.4
• /
• pp.216-219
• /
• 2012

Structure-based drug design possibly benefit from in silico methods that precisely predict the binding affinity of small molecules to target macromolecules. There are many limitations arise from the difficulty of predicting the binding affinity of a small molecule to a biological target with the current scoring functions. There is thus a strong interest in novel methodologies based on MD simulations that claim predictions of greater accuracy than current scoring functions, helpful for a regular use designed for drug discovery in the pharmaceutical industry. Herein, we report a short review on free energy calculations using MMPBSA method a useful method in structure based drug discovery.

• Proceedings of the Korea Inteligent Information System Society Conference
• /
• 2001.01a
• /
• pp.431-434
• /
• 2001

Knowledge discovery in databases(KDD) is the process for extracting valid, novel, potentially useful and understandable knowledge form real data. There are many academic and industrial activities with new technologies and application areas. Particularly, data mining is the core step in the KDD process, consisting of many algorithms to perform clustering, pattern recognition and rule induction functions. The main goal of these algorithms is prediction and description. Prediction means the assessment of unknown variables. Description is concerned with providing understandable results in a compatible format to human users. We introduce an efficient data mining algorithm considering predictive and descriptive capability. Reasonable pattern is derived from real world data by a revised neural network model and a proposed fuzzy rule extraction technique is applied to obtain understandable knowledge. The proposed neural network model is a hierarchical self-organizing system. The rule base is compatible to decision makers perception because the generated fuzzy rule set reflects the human information process. Results from real world application are analyzed to evaluate the system\`s performance.

• BMB Reports
• /
• v.37 no.1
• /
• pp.28-34
• /
• 2004

The discovery of biochemical and cellular functions of unannotated gene products begins with a database search of proteins with structure/sequence homologues based on known genes. Very recently, a number of frontier groups in structural biology proposed a new paradigm to predict biological functions of an unknown protein on the basis of its three-dimensional structure on a genomic scale. Structural proteomics (genomics), a research area for structure-based functional discovery, aims to complete the protein-folding universe of all gene products in a cell. It would lead us to a complete understanding of a living organism from protein structure. Two major complementary experimental techniques, X-ray crystallography and NMR spectroscopy, combined with recently developed high throughput methods have played a central role in structural proteomics research; however, an integration of these methodologies together with comparative modeling and electron microscopy would speed up the goal for completing a full dictionary of protein folding space in the near future.

• BMB Reports
• /
• v.45 no.6
• /
• pp.323-330
• /
• 2012

The glycome consists of all glycans (or carbohydrates) within a biological system, and modulates a wide range of important biological activities, from protein folding to cellular communications. The mining of the glycome for disease markers represents a new paradigm for biomarker discovery; however, this effort is severely complicated by the vast complexity and structural diversity of glycans. This review summarizes recent developments in analytical technology and methodology as applied to the fields of glycomics and glycoproteomics. Mass spectrometric strategies for glycan compositional profiling are described, as are potential refinements which allow structure-specific profiling. Analytical methods that can discern protein glycosylation at a specific site of modification are also discussed in detail. Biomarker discovery applications are shown at each level of analysis, highlighting the key role that glycoscience can play in helping scientists understand disease biology.

• Proceedings of the KIEE Conference
• /
• 2005.10b
• /
• pp.448-450
• /
• 2005

A ubiquitous network allows all users to access and exchange information of any kind freely at any time, from anywhere, and from any appliance through the use of broadband and mobile access. Bluetooth commincation can provide the missing wireless extension to the heterogeneous network, allowing a more ubiquitous access. In this point of view, the BT specifications define ways for which each BT device can set up multiple connections with neighboring devices to communicate in a multi-hop fashion. this paper provides insights on the Bluetooth technology and on some limitations of the scatternet formations. so that, we describe a new multi-hop routing protocol for the establishment of scatternets. this protocol defines rules for forming a multi-hop topology in two phases. the first phase, topology discovery, concerns the discovery of the node's depth from a root node initiating inquiry process. the second phase forms scatternet topology based on the result of topology discovery.

• Proceedings of the IEEK Conference
• /
• 2002.07b
• /
• pp.1224-1227
• /
• 2002

In this paper, we propose a composition method of the template image whose detection performance does not have incorrect detection and improves also on the tough photography conditions of the outdoors, rainy weather and night. This research was done to measure a relative position between a spreader and a target container with image processing to realize full-automatic quayside gantry cranes. By the proposal method, we confirmed that the template image for object detection has a contour image more effective than a gray image.

• Interdisciplinary Bio Central
• /
• v.2 no.4
• /
• pp.9.1-9.5
• /
• 2010

Many neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, are devastating disorders that affect millions of people worldwide. However, the number of therapeutic options remains severely limited with only symptomatic management therapies available. With the better understanding of the pathogenesis of neurodegenerative diseases, discovery efforts for disease-modifying drugs have increased dramatically in recent years. However, the process of translating basic science discovery into novel therapies is still lagging behind for various reasons. The task of finding new effective drugs targeting central nervous system (CNS) has unique challenges due to blood-brain barrier (BBB). Furthermore, the relatively slow progress of neurodegenerative disorders create another level of difficulty, as clinical trials must be carried out for an extended period of time. This review is intended to provide molecular and cell biologists with working knowledge and resources on CNS drug discovery and development.

• Knowledge Management Research
• /
• v.2 no.1
• /
• pp.109-132
• /
• 2001

The purpose of this article is to develop a dynamic model of organizational capabilities and knowledge creation, and at the same time identify the organizational capability factors for effective knowledge creation, by empirically analyzing the history of new Quinolone antibacterial drug compound (LB20304a) discovery process at LG, as a case in point. Major findings of this study are as follows. First, in a science-based area such as drug development, the core of successful knowledge creation lies in creative combination of different bodies of scientific explicit knowledge. Second, the greater the difficulty of learning external knowledge, the more tacit knowledge is needed for the recipient firm to effectively exploit that knowledge. Third, in science-based sector such as pharmaceutical industry, the key for successful knowledge creation lies in the capability of recruiting and retaining star scientists. Finally, for effective knowledge creation, a firm must keep its balance among three dimensions of organizational capabilities: local, process, architectural capabilities.